# RubrYc Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rubryc-therapeutics

- Industry: Biotechnology
- Headquarters: San Carlos, US
- Total disclosed funding: $18M
- Latest round: Series A (Aug 25, 2021)
- Investors on record: 5

## About

Founded in 2017 and based in California, US, RubrYc Therapeutics, Inc. operates as a biotechnology company that develops molecular therapeutic antibodies using its proprietary machine learning and computational biology technologies.

## Funding rounds

- Series A, Aug 25, 2021, $7.5M — Paladin Capital Group, Third Point, Vital Venture Capital, Hayan Health Networks, iBio, Inc.
- Series A, Apr 4, 2018, $10M — Paladin Capital Group, Third Point, Vital Venture Capital

## Investors

- Paladin Capital Group (https://capitalatlas.ai/funds/paladin-capital-group) — Series A
- Third Point (https://capitalatlas.ai/funds/third-point) — Series A
- Vital Venture Capital (https://capitalatlas.ai/funds/vital-venture-capital) — Series A
- Hayan Health Networks (https://capitalatlas.ai/funds/hayan-health-networks) — Series A
- iBio, Inc. — Series A